Inside the fentanyl trade powering the world’s deadliest drug crisis
Times: Last year the drug killed more young Americans than car accidents or guns.
Times: Last year the drug killed more young Americans than car accidents or guns.
Seymour wants investigation of possible cost-sharing between Pharmac and patients.
Psychiatrists say disruption could cause some patients to suffer relapse of psychosis.
The scheme won't cover all multiple myeloma patients. Details are due within a month.
Dr Logan McLennan's former patients are stepping forward to help the beloved GP.
Lady Tureiti Moxon says the decision is ‘another anti-Maōri stance’.
Telegraph: Professor Tara Spires-Jones on causes, symptoms, diagnosis and treatment.
Jayant Patel was caught when the pharmacy owner noticed extra medication and viewed CCTV.
New Zealand badly lags behind other developed countries for funded myeloma drugs.
Medical botch-up led to woman having to delay having children.
New York Times: The pill lowers testosterone. What does that do to libido?
Telegraph: There's no miracle solution, but these are the treatments that can help.
Return of $5 fee could affect how community pharmacies compete, says spokesman.
New York Times: Experts explain what dieting can — and can’t — do for you.
Here's what to do with expired or unused medicines sitting in your cupboard.
New York Times: 'I have a predisposition that no amount of willpower is going to control.'
Brash newcomer would merge to create huge new pharmacy company.
'You’re not doing your country any good to put it on the shelves.'
Act leader David Seymour at the signing of the coalition agreement with National and NZ First says pseudoephedrine will be back on shelves in time for next winter. Video / Mark Mitchell
Ebos had been in a trading halt since last week.
Telegraph: Considering hormone replacement therapy? Here's what you need to know.
Global demand has been blamed for the shortage of Teva, a common ADHD drug.
NY Times: Some patients say symptoms persist long after they've stopped taking SSRIs.
Wegovy has been found to have a 'quite profound' effect on reducing heart attack risk.
"We have taken the eye off methamphetamine."
Telegraph: Menopause has come out of the shadows. So have the snake oil merchants.
New York Times: 'These medications were not studied well or designed for this population.'
Rule change a 'surprise' but health regulator claims potential safety issues exist.
Financial Times: Global data on new cases of dementia offers an unexpected ray of hope.
Pharmac's board met today amid a deepening crisis over internal emails.